Trial NCT02579863

View at ClinicalTrials.gov 
Org. Study IDs: 3475-185
Secondary IDs: 163239 2015-002901-12 KEYNOTE-185 MK-3475-185

Last trial update was posted on 2021-07-20

MeSH Interventions

Dexamethasone Lenalidomide Pembrolizumab

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

The study was terminated early due to business reasons

Limitations And Caveats

The MK-3475-185 study was stopped/terminated early. Endpoint statistics may be biased due to the incomplete treatment and follow-up of participants after study termination

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID